Antonino Musolino

Associate Professor

University of Parma

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Antonino Musolino is an Associate Professor at the University of Parma, Italy. His research primarily focuses on oncology, with recent publications addressing topics such as PARP inhibition in melanoma, therapeutic strategies in gynecological tumors, and the impact of COVID-19 on cancer patients. He has also explored the genetic underpinnings of breast cancer and contributed to the understanding of tumor behavior through translational research.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Andrea Sartore-Bianchi

Associate Professor

Università degli Studi di Torino

ITALY

View details

Giovanni Maifredi

ITALY

View details

Sergio Marchini

Head Humanitas Genomic Facility (HuGe)

IRCCS Humanitas Research Hospital

ITALY

View details

Matteo Benelli

Head of Bioinformatics Unit

Azienda Usl Toscana Centro

ITALY

View details

Mario Scartozzi

ITALY

View details

Andrea Vingiani

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Tjalling Bosse

Associate Professor

Leiden University Medical Center

NETHERLANDS

View details

William Bruno

Assistant professor

Ospedale Policlinico San Martino

ITALY

View details

Paolo Contiero

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Enrico Berrino

Università degli Studi di Foggia Dipartimento di Scienze Mediche e Chirurgiche

ITALY

View details

Lauro Bucchi

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ITALY

View details

Luca Mastracci

Consultant - Assistant Professor

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro

ITALY

View details

Seock-Ah Im

Professor

Seoul National University College of Medicine

SOUTH KOREA

View details

sara erika bellomo

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antonino Musolino

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Assessing Determinants of Response to PARP Inhibition in Germline <i>ATM</i> Mutant Melanoma

Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019

SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy

Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors

Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial

Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants

Prevalence and indicators of cure of Italian women with vulvar squamous cell carcinoma: A population-based study

Transcriptomic profiling of circulating tumor cells from metastatic breast cancer patients reveals new hints in their biological features and phenotypic heterogeneity

Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical Trial

Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)

BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients

Influence of Sex and Age on Site of Onset, Morphology, and Site of Metastasis in Colorectal Cancer: A Population-Based Study on Data from Four Italian Cancer Registries

Margetuximab Versus Trastuzumab in Patients with Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results from a Randomized Phase 3 Trial

Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations

RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test

Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm?

Trends in Liver Cancer Incidence and Survival in Italy by Histologic Type, 2003–2017

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer

Collaborators (14)

Andrea Sartore-Bianchi

Giovanni Maifredi

Sergio Marchini

Matteo Benelli

Mario Scartozzi

Andrea Vingiani

Tjalling Bosse

William Bruno

Paolo Contiero

Enrico Berrino

Lauro Bucchi

Luca Mastracci

Seock-Ah Im

sara erika bellomo

Make your next move.